{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:33:18Z","timestamp":1794940398650,"version":"4.9.1"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CIBER-Consorcio Centro de Investigaci\u00f3n Biom\u00e9dica en Red,  Instituto de Salud Carlos III, Ministerio de Ciencia e Innovaci\u00f3n","award":["CB15\/00071"],"award-info":[{"award-number":["CB15\/00071"]}]},{"name":"CIBER-Consorcio Centro de Investigaci\u00f3n Biom\u00e9dica en Red,  Instituto de Salud Carlos III, Ministerio de Ciencia e Innovaci\u00f3n","award":["CB15\/00071"],"award-info":[{"award-number":["CB15\/00071"]}]},{"name":"Uni\u00f3n Europea \u2013 European Regional Development Fund."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetes microangiopathy, a hallmark complication of diabetes, is characterised by structural and functional abnormalities within the intricate network of microvessels beyond well-known and documented target organs, i.e., the retina, kidney, and peripheral nerves. Indeed, an intact microvascular bed is crucial for preserving each organ\u2019s specific functions and achieving physiological balance to meet their respective metabolic demands. Therefore, diabetes-related microvascular dysfunction leads to widespread multiorgan consequences in still-overlooked non-traditional target organs such as the brain, the lung, the bone tissue, the skin, the arterial wall, the heart, or the musculoskeletal system. All these organs are vulnerable to the physiopathological mechanisms that cause microvascular damage in diabetes (i.e., hyperglycaemia-induced oxidative stress, inflammation, and endothelial dysfunction) and collectively contribute to abnormalities in the microvessels\u2019 structure and function, compromising blood flow and tissue perfusion. However, the microcirculatory networks differ between organs due to variations in haemodynamic, vascular architecture, and affected cells, resulting in a spectrum of clinical presentations. The aim of this review is to focus on the multifaceted nature of microvascular impairment in diabetes through available evidence of specific consequences in often overlooked organs. A better understanding of diabetes microangiopathy in non-target organs provides a broader perspective on the systemic nature of the disease, underscoring the importance of recognising the comprehensive range of complications beyond the classic target sites.<\/jats:p>","DOI":"10.1186\/s12933-023-02056-3","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:02:59Z","timestamp":1700078579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves"],"prefix":"10.1186","volume":"22","author":[{"given":"D\u00eddac","family":"Mauricio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Gratac\u00f2s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"2056_CR1","doi-asserted-by":"crossref","unstructured":"Lenasi H. Introductory Chapter: Microcirculation in Health and Disease. In: Microcirculation Revisited Edited by Helena L. Rijeka: IntechOpen; 2016: Ch. 1.","DOI":"10.5772\/64680"},{"issue":"1\u20132","key":"2056_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000503775","volume":"49","author":"G Guven","year":"2020","unstructured":"Guven G, Hilty MP, Ince C, Microcirculation. Physiology, pathophysiology, and clinical application. Blood Purif. 2020;49(1\u20132):143\u201350.","journal-title":"Blood Purif"},{"key":"2056_CR3","doi-asserted-by":"crossref","unstructured":"Fleischer S, Tavakol DN, Vunjak-Novakovic G. From arteries to capillaries: approaches to engineering human vasculature. Adv Funct Mater. 2020;30(37).","DOI":"10.1002\/adfm.201910811"},{"key":"2056_CR4","doi-asserted-by":"crossref","unstructured":"Johnson PC. Overview of microcirculation. In: Handbook of Physiology: Microcirculation Edited by Ronald F. Tuma WND, Klaus Ley 2nd edn. San Diego, CA: Academic Press; 2008.","DOI":"10.1016\/B978-0-12-374530-9.00022-X"},{"issue":"11","key":"2056_CR5","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753\u201386.","journal-title":"Diabetes Care"},{"issue":"1","key":"2056_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","volume":"42","author":"WB Horton","year":"2021","unstructured":"Horton WB, Barrett EJ. Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease. Endocr Rev. 2021;42(1):29\u201355.","journal-title":"Endocr Rev"},{"issue":"12","key":"2056_CR7","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1210\/jc.2017-01922","volume":"102","author":"EJ Barrett","year":"2017","unstructured":"Barrett EJ, Liu Z, Khamaisi M, King GL, Klein R, Klein BEK, et al. Diabetic microvascular Disease: an endocrine Society Scientific statement. J Clin Endocrinol Metab. 2017;102(12):4343\u2013410.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2056_CR8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic Complications. Circ Res. 2010;107(9):1058\u201370.","journal-title":"Circ Res"},{"issue":"6865","key":"2056_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic Complications. Nature. 2001;414(6865):813\u201320.","journal-title":"Nature"},{"issue":"6","key":"2056_CR10","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic Complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325.","journal-title":"Diabetes"},{"issue":"1","key":"2056_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1152\/physrev.00001.2019","volume":"100","author":"CG Schalkwijk","year":"2020","unstructured":"Schalkwijk CG, Stehouwer CDA. Methylglyoxal, a highly reactive dicarbonyl compound, in Diabetes, its vascular Complications, and other Age-Related Diseases. Physiol Rev. 2020;100(1):407\u201361.","journal-title":"Physiol Rev"},{"key":"2056_CR12","doi-asserted-by":"crossref","unstructured":"Stratmann B. Dicarbonyl stress in Diabetic Vascular Disease. Int J Mol Sci 2022;23(11).","DOI":"10.3390\/ijms23116186"},{"key":"2056_CR13","doi-asserted-by":"crossref","unstructured":"Takeda Y, Matoba K, Sekiguchi K, Nagai Y, Yokota T, Utsunomiya K et al. Endothelial dysfunction in Diabetes. In: Biomedicines vol. 8; 2020.","DOI":"10.3390\/biomedicines8070182"},{"issue":"4","key":"2056_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/path.1439","volume":"200","author":"EC Tsilibary","year":"2003","unstructured":"Tsilibary EC. Microvascular basement membranes in Diabetes Mellitus. J Pathol. 2003;200(4):537\u201346.","journal-title":"J Pathol"},{"issue":"2","key":"2056_CR15","doi-asserted-by":"publisher","first-page":"200360","DOI":"10.1098\/rsob.200360","volume":"11","author":"N Khalilgharibi","year":"2021","unstructured":"Khalilgharibi N, Mao Y. To form and function: on the role of basement membrane mechanics in tissue development, homeostasis and Disease. Open Biol. 2021;11(2):200360.","journal-title":"Open Biol"},{"key":"2056_CR16","doi-asserted-by":"crossref","unstructured":"Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis G-A, Vogiatzi G, Papaioannou S et al. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. European Cardiology Review 2019;14(1):50\u20139. 2019.","DOI":"10.15420\/ecr.2018.33.1"},{"issue":"11","key":"2056_CR17","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1210\/jc.2019-00980","volume":"104","author":"GP Fadini","year":"2019","unstructured":"Fadini GP, Albiero M, Bonora BM, Avogaro A. Angiogenic abnormalities in Diabetes Mellitus: mechanistic and clinical aspects. J Clin Endocrinol Metabolism. 2019;104(11):5431\u201344.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2056_CR18","doi-asserted-by":"crossref","unstructured":"Li X, Weber NC, Cohn DM, Hollmann MW, DeVries JH, Hermanides J et al. Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis. J Clin Med. 2021;10(11).","DOI":"10.3390\/jcm10112419"},{"key":"2056_CR19","doi-asserted-by":"crossref","unstructured":"Sena CM, Pereira AM, Sei\u00e7a R. Endothelial dysfunction \u2014 a major mediator of diabetic vascular Disease. Biochimica et Biophysica Acta (BBA) - molecular basis of Disease. 2013;1832(12):2216\u201331.","DOI":"10.1016\/j.bbadis.2013.08.006"},{"issue":"9","key":"2056_CR20","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2337\/dbi17-0044","volume":"67","author":"CDA Stehouwer","year":"2018","unstructured":"Stehouwer CDA. Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences. Diabetes. 2018;67(9):1729\u201341.","journal-title":"Diabetes"},{"issue":"9","key":"2056_CR21","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","volume":"472","author":"A Chadt","year":"2020","unstructured":"Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and Disease. Pfl\u00fcgers Archiv - European Journal of Physiology. 2020;472(9):1273\u201398.","journal-title":"Pfl\u00fcgers Archiv - European Journal of Physiology"},{"issue":"1","key":"2056_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00441-008-0685-6","volume":"335","author":"W Bakker","year":"2009","unstructured":"Bakker W, Eringa EC, Sipkema P, van Hinsbergh VWM. Endothelial dysfunction and Diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009;335(1):165\u201389.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2056_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4103\/jomfp.JOMFP_22_18","volume":"23","author":"S Pragallapati","year":"2019","unstructured":"Pragallapati S, Manyam R. Glucose transporter 1 in health and Disease. J Oral Maxillofac Pathol. 2019;23(3):443\u20139.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"4","key":"2056_CR24","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s13311-021-01150-2","volume":"18","author":"A Rawat","year":"2021","unstructured":"Rawat A, Morrison BM. Metabolic transporters in the peripheral Nerve\u2014What, where, and why? Neurotherapeutics. 2021;18(4):2185\u201399.","journal-title":"Neurotherapeutics"},{"key":"2056_CR25","doi-asserted-by":"crossref","unstructured":"Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl. 2011;(120):S1\u20136.","DOI":"10.1038\/ki.2010.509"},{"issue":"1","key":"2056_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular Diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Therapy. 2023;8(1):152.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1\u20132","key":"2056_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1113\/jphysiol.1890.sp000321","volume":"11","author":"CS Roy","year":"1890","unstructured":"Roy CS, Sherrington CS. On the regulation of the blood-supply of the brain. J Physiol. 1890;11(1\u20132):85\u2013158.","journal-title":"J Physiol"},{"issue":"1","key":"2056_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids and Barriers of the CNS. 2020;17(1):69.","journal-title":"Fluids and Barriers of the CNS"},{"key":"2056_CR29","doi-asserted-by":"crossref","unstructured":"Erdener \u015eE, Dalkara T. Small vessels are a big Problem in Neurodegeneration and Neuroprotection. Front Neurol. 2019;10.","DOI":"10.3389\/fneur.2019.00889"},{"issue":"1","key":"2056_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C","volume":"21","author":"SJ Vannucci","year":"1997","unstructured":"Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia. 1997;21(1):2\u201321.","journal-title":"Glia"},{"issue":"2","key":"2056_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4093\/dmj.2021.0146","volume":"46","author":"X Li","year":"2022","unstructured":"Li X, Cai Y, Zhang Z, Zhou J. Glial and vascular cell regulation of the blood-brain barrier in Diabetes. Diabetes Metab J. 2022;46(2):222\u201338.","journal-title":"Diabetes Metab J"},{"key":"2056_CR32","doi-asserted-by":"crossref","unstructured":"Garcia-Serrano AM, Duarte JMN. Brain metabolism alterations in type 2 Diabetes: what did we learn from Diet-Induced Diabetes models? Front Neurosci. 2020;14.","DOI":"10.3389\/fnins.2020.00229"},{"issue":"1","key":"2056_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"JM Starr","year":"2003","unstructured":"Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II Diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2003;74(1):70\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2056_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00125-006-0485-z","volume":"50","author":"BT Hawkins","year":"2007","unstructured":"Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD. Increased blood-brain barrier permeability and altered tight junctions in experimental Diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia. 2007;50(1):202\u201311.","journal-title":"Diabetologia"},{"key":"2056_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","volume":"46","author":"B D\u00edaz-Castro","year":"2023","unstructured":"D\u00edaz-Castro B, Robel S, Mishra A. Astrocyte endfeet in brain function and Pathology: open questions. Annu Rev Neurosci. 2023;46:101\u201321.","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"2056_CR36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/HYPERTENSIONAHA.112.192401","volume":"59","author":"LJ Min","year":"2012","unstructured":"Min LJ, Mogi M, Shudou M, Jing F, Tsukuda K, Ohshima K, et al. Peroxisome proliferator-activated receptor-\u03b3 activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension. 2012;59(5):1079\u201388.","journal-title":"Hypertension"},{"issue":"2","key":"2056_CR37","doi-asserted-by":"publisher","first-page":"e00030","DOI":"10.1042\/AN20090048","volume":"2","author":"GK Gandhi","year":"2010","unstructured":"Gandhi GK, Ball KK, Cruz NF, Dienel GA. Hyperglycaemia and Diabetes impair gap junctional communication among astrocytes. ASN Neuro. 2010;2(2):e00030.","journal-title":"ASN Neuro"},{"issue":"8","key":"2056_CR38","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jdiacomp.2016.08.005","volume":"30","author":"N Warmke","year":"2016","unstructured":"Warmke N, Griffin KJ, Cubbon RM. Pericytes in diabetes-associated vascular Disease. J Diabetes Complications. 2016;30(8):1643\u201350.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"2056_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005;7(4):452\u201364.","journal-title":"Neuro Oncol"},{"key":"2056_CR40","doi-asserted-by":"crossref","unstructured":"Patrick P, Price TO, Diogo AL, Sheibani N, Banks WA, Shah GN. Topiramate protects pericytes from glucotoxicity: role for mitochondrial CA VA in Cerebromicrovascular Disease in Diabetes. J Endocrinol Diabetes. 2015;2(2).","DOI":"10.15226\/2374-6890\/2\/2\/00123"},{"key":"2056_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pharmthera.2016.11.008","volume":"171","author":"D Ferland-McCollough","year":"2017","unstructured":"Ferland-McCollough D, Slater S, Richard J, Reni C, Mangialardi G. Pericytes, an overlooked player in vascular pathobiology. Pharmacol Ther. 2017;171:30\u201342.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"2056_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel Disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483\u201397.","journal-title":"Lancet Neurol"},{"issue":"9","key":"2056_CR43","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and Dementia: a statement for healthcare professionals from the American heart association\/american Stroke association. Stroke. 2011;42(9):2672\u2013713.","journal-title":"Stroke"},{"issue":"8","key":"2056_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel Disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"issue":"7","key":"2056_CR45","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","volume":"22","author":"M Duering","year":"2023","unstructured":"Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw F-E, et al. Neuroimaging standards for research into small vessel Disease\u2013advances since 2013. Lancet Neurol. 2023;22(7):602\u201318.","journal-title":"Lancet Neurol"},{"issue":"51","key":"2056_CR46","doi-asserted-by":"publisher","first-page":"e28229","DOI":"10.1097\/MD.0000000000028229","volume":"100","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen Q, Chen J, Yang N, Zheng K. Risk factors of cerebral small vessel Disease: a systematic review and meta-analysis. Med (Baltim). 2021;100(51):e28229.","journal-title":"Med (Baltim)"},{"key":"2056_CR47","doi-asserted-by":"crossref","unstructured":"Eriksson MI, Summanen P, Gordin D, Forsblom C, Shams S, Liebkind R et al. Cerebral small-vessel Disease is associated with the severity of diabetic retinopathy in type 1 Diabetes. BMJ Open Diabetes Res Care. 2021;9(1).","DOI":"10.1136\/bmjdrc-2021-002274"},{"issue":"9","key":"2056_CR48","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2337\/dc15-2671","volume":"39","author":"J Sanahuja","year":"2016","unstructured":"Sanahuja J, Alonso N, Diez J, Ortega E, Rubinat E, Traveset A, et al. Increased burden of cerebral small vessel Disease in patients with type 2 Diabetes and retinopathy. Diabetes Care. 2016;39(9):1614\u201320.","journal-title":"Diabetes Care"},{"issue":"3","key":"2056_CR49","doi-asserted-by":"publisher","first-page":"e12530","DOI":"10.1111\/micc.12530","volume":"26","author":"AL Emanuel","year":"2019","unstructured":"Emanuel AL, van Duinkerken E, Wattjes MP, Klein M, Barkhof F, Snoek FJ, et al. The presence of cerebral white matter lesions and lower skin microvascular perfusion predicts lower cognitive performance in type 1 Diabetes patients with retinopathy but not in healthy controls-A longitudinal study. Microcirculation. 2019;26(3):e12530.","journal-title":"Microcirculation"},{"key":"2056_CR50","doi-asserted-by":"publisher","first-page":"595962","DOI":"10.3389\/fendo.2020.595962","volume":"11","author":"DQ Wang","year":"2020","unstructured":"Wang DQ, Wang L, Wei MM, Xia XS, Tian XL, Cui XH, et al. Relationship between type 2 Diabetes and White Matter Hyperintensity: a systematic review. Front Endocrinol (Lausanne). 2020;11:595962.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2056_CR51","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.euroneuro.2014.01.023","volume":"24","author":"M Brundel","year":"2014","unstructured":"Brundel M, Kappelle LJ, Biessels GJ. Brain imaging in type 2 Diabetes. Eur Neuropsychopharmacol. 2014;24(12):1967\u201381.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"2056_CR52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000519327","volume":"55","author":"L Zhang","year":"2021","unstructured":"Zhang L, Li X, Wolfe CDA, O\u2019Connell MDL, Wang Y. Diabetes as an Independent risk factor for Stroke recurrence in ischemic Stroke patients: an updated Meta-analysis. Neuroepidemiology. 2021;55(6):427\u201335.","journal-title":"Neuroepidemiology"},{"issue":"4","key":"2056_CR53","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11682-014-9348-2","volume":"9","author":"CD Moulton","year":"2015","unstructured":"Moulton CD, Costafreda SG, Horton P, Ismail K, Fu CH. Meta-analyses of structural regional cerebral effects in type 1 and type 2 Diabetes. Brain Imaging Behav. 2015;9(4):651\u201362.","journal-title":"Brain Imaging Behav"},{"key":"2056_CR54","doi-asserted-by":"crossref","unstructured":"van Duinkerken E, Ijzerman RG. Cerebral Microvascular Disease in Diabetes \u2013 Clinical and Research. In: Microvascular Disease in Diabetes 2020: 221 \u2013 46.","DOI":"10.1002\/9781119309642.ch14"},{"issue":"4","key":"2056_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","volume":"8","author":"TT van Sloten","year":"2020","unstructured":"van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular Complications of type 2 Diabetes: stroke, cognitive dysfunction, and depression. The Lancet Diabetes & Endocrinology. 2020;8(4):325\u201336.","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"4","key":"2056_CR56","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2337\/dc13-1586","volume":"37","author":"J Woerdeman","year":"2014","unstructured":"Woerdeman J, van Duinkerken E, Wattjes MP, Barkhof F, Snoek FJ, Moll AC, et al. Proliferative retinopathy in type 1 Diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy. Diabetes Care. 2014;37(4):1165\u20138.","journal-title":"Diabetes Care"},{"issue":"4","key":"2056_CR57","doi-asserted-by":"publisher","first-page":"e3261","DOI":"10.1002\/dmrr.3261","volume":"36","author":"JB Zhou","year":"2020","unstructured":"Zhou JB, Tang XY, Han YP, Luo FQ, Cardoso MA, Qi L. Prediabetes and structural brain abnormalities: evidence from observational studies. Diabetes Metab Res Rev. 2020;36(4):e3261.","journal-title":"Diabetes Metab Res Rev"},{"key":"2056_CR58","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.arr.2019.100944","volume":"55","author":"M Xue","year":"2019","unstructured":"Xue M, Xu W, Ou Y-N, Cao X-P, Tan M-S, Tan L, et al. Diabetes Mellitus and risks of cognitive impairment and Dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"2056_CR59","doi-asserted-by":"publisher","first-page":"e011020186496","DOI":"10.2174\/1573399816999201001203652","volume":"17","author":"H Omana","year":"2021","unstructured":"Omana H, Madou E, Montero-Odasso M, Payne M, Viana R, Hunter S. The Effect of Dual-Task Testing on Balance and Gait performance in adults with type 1 or type 2 Diabetes Mellitus: a systematic review. Curr Diabetes Rev. 2021;17(5):e011020186496.","journal-title":"Curr Diabetes Rev"},{"key":"2056_CR60","doi-asserted-by":"crossref","unstructured":"Gao Y, Li D, Lin J, Thomas AM, Miao J, Chen D et al. Cerebral small vessel Disease: pathological mechanisms and potential therapeutic targets. Front Aging Neurosci. 2022;14.","DOI":"10.3389\/fnagi.2022.961661"},{"issue":"11","key":"2056_CR61","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/j.1464-5491.2006.01943.x","volume":"23","author":"S Ali","year":"2006","unstructured":"Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 Diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11):1165\u201373.","journal-title":"Diabet Med"},{"issue":"12","key":"2056_CR62","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/dme.14054","volume":"36","author":"A Nouwen","year":"2019","unstructured":"Nouwen A, Adriaanse MC, van Dam K, Iversen MM, Viechtbauer W, Peyrot M, et al. Longitudinal associations between depression and Diabetes Complications: a systematic review and meta-analysis. Diabet Med. 2019;36(12):1562\u201372.","journal-title":"Diabet Med"},{"issue":"8","key":"2056_CR63","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.2337\/dc19-2437","volume":"43","author":"SP Rensma","year":"2020","unstructured":"Rensma SP, van Sloten TT, Ding J, Sigurdsson S, Stehouwer CDA, Gudnason V, et al. Type 2 Diabetes, change in depressive symptoms over Time, and Cerebral Small Vessel Disease: Longitudinal Data of the AGES-Reykjavik Study. Diabetes Care. 2020;43(8):1781\u20137.","journal-title":"Diabetes Care"},{"issue":"6","key":"2056_CR64","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10654-023-00970-0","volume":"38","author":"D Aune","year":"2023","unstructured":"Aune D, Schlesinger S, Mahamat-Saleh Y, Zheng B, Udeh-Momoh CT, Middleton LT. Diabetes Mellitus, prediabetes and the risk of Parkinson\u2019s Disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases. Eur J Epidemiol. 2023;38(6):591\u2013604.","journal-title":"Eur J Epidemiol"},{"key":"2056_CR65","doi-asserted-by":"crossref","unstructured":"Zhong Q, Wang S. Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson\u2019s disease: A systematic review and meta-analysis. Front Aging Neurosci. 2023;15.","DOI":"10.3389\/fnagi.2023.1109914"},{"issue":"12","key":"2056_CR66","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.2337\/dc11-1584","volume":"34","author":"E Cereda","year":"2011","unstructured":"Cereda E, Barichella M, Pedrolli C, Klersy C, Cassani E, Caccialanza R, et al. Diabetes and risk of Parkinson\u2019s Disease: a systematic review and meta-analysis. Diabetes Care. 2011;34(12):2614\u201323.","journal-title":"Diabetes Care"},{"key":"2056_CR67","doi-asserted-by":"publisher","first-page":"800973","DOI":"10.3389\/fmed.2021.800973","volume":"8","author":"D Mauricio","year":"2021","unstructured":"Mauricio D, Vlacho B, de la Barrot J, Mundet-Tudur\u00ed X, Real J, Kulisevsky J, et al. Associations between Diabetic Retinopathy and Parkinson\u2019s Disease: results from the Catalonian Primary Care Cohort Study. Front Med (Lausanne). 2021;8:800973.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"2056_CR68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/cphy.c140049","volume":"6","author":"K Suresh","year":"2016","unstructured":"Suresh K, Shimoda LA. Lung circulation. Compr Physiol. 2016;6(2):897\u2013943.","journal-title":"Compr Physiol"},{"issue":"8","key":"2056_CR69","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4239\/wjd.v11.i8.351","volume":"11","author":"V Rajasurya","year":"2020","unstructured":"Rajasurya V, Gunasekaran K, Surani S. Interstitial lung Disease and Diabetes. World J Diabetes. 2020;11(8):351\u20137.","journal-title":"World J Diabetes"},{"key":"2056_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1900\/RDS.2019.15.1","volume":"15","author":"J Khateeb","year":"2019","unstructured":"Khateeb J, Fuchs E, Khamaisi M. Diabetes and lung Disease: a neglected relationship. Rev Diabet Stud. 2019;15:1\u201315.","journal-title":"Rev Diabet Stud"},{"key":"2056_CR71","doi-asserted-by":"publisher","first-page":"1073878","DOI":"10.3389\/fendo.2023.1073878","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiang F, Xie Y, Mo Y, Zhang X, Liu C. Diabetic endothelial microangiopathy and pulmonary dysfunction. Front Endocrinol (Lausanne). 2023;14:1073878.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2056_CR72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/1753-0407.12521","volume":"9","author":"Y Shi","year":"2017","unstructured":"Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in Diabetes. J Diabetes. 2017;9(5):434\u201349.","journal-title":"J Diabetes"},{"issue":"1","key":"2056_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14336\/AD.2016.0627","volume":"8","author":"H Zheng","year":"2017","unstructured":"Zheng H, Wu J, Jin Z, Yan LJ. Potential biochemical mechanisms of Lung Injury in Diabetes. Aging Dis. 2017;8(1):7\u201316.","journal-title":"Aging Dis"},{"issue":"7","key":"2056_CR74","first-page":"35","volume":"44","author":"IM Kodolova","year":"1982","unstructured":"Kodolova IM, Lysenko LV, Saltykov BB. [Changes in the lungs in Diabetes Mellitus]. Arkh Patol. 1982;44(7):35\u201340.","journal-title":"Arkh Patol"},{"issue":"1","key":"2056_CR75","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000029331","volume":"66","author":"B Weynand","year":"1999","unstructured":"Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes Mellitus induces a thickening of the pulmonary basal lamina. Respiration. 1999;66(1):14\u20139.","journal-title":"Respiration"},{"issue":"5","key":"2056_CR76","first-page":"973","volume":"120","author":"R Vracko","year":"1979","unstructured":"Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in Diabetes Mellitus. Am Rev Respir Dis. 1979;120(5):973\u201383.","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"2056_CR77","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00203738","volume":"427","author":"J Fari\u00f1a","year":"1995","unstructured":"Fari\u00f1a J, Furi\u00f3 V, Fernandez-Ace\u00f1ero MJ, Muzas MA. Nodular fibrosis of the lung in Diabetes Mellitus. Virchows Arch. 1995;427(1):61\u20133.","journal-title":"Virchows Arch"},{"issue":"1","key":"2056_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1164\/arrd.1983.128.1.125","volume":"128","author":"K Kida","year":"1983","unstructured":"Kida K, Utsuyama M, Takizawa T, Thurlbeck WM. Changes in lung morphologic features and elasticity caused by streptozotocin-induced Diabetes Mellitus in growing rats. Am Rev Respir Dis. 1983;128(1):125\u201331.","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"2056_CR79","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1164\/ajrccm\/137.1.162","volume":"137","author":"AF Ofulue","year":"1988","unstructured":"Ofulue AF, Kida K, Thurlbeck WM. Experimental Diabetes and the lung. I. changes in growth, morphometry, and biochemistry. Am Rev Respir Dis. 1988;137(1):162\u20136.","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"2056_CR80","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1164\/ajrccm\/138.2.284","volume":"138","author":"AF Ofulue","year":"1988","unstructured":"Ofulue AF, Thurlbeck WM. Experimental Diabetes and the lung. II. In vivo connective tissue metabolism. Am Rev Respir Dis. 1988;138(2):284\u20139.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"2056_CR81","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000264920","volume":"79","author":"G Eren","year":"2010","unstructured":"Eren G, Cukurova Z, Hergunsel O, Demir G, Kucur M, Uslu E, et al. Protective effect of the nuclear factor kappa B inhibitor pyrrolidine dithiocarbamate in lung injury in rats with streptozotocin-induced Diabetes. Respiration. 2010;79(5):402\u201310.","journal-title":"Respiration"},{"issue":"4","key":"2056_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s005920050090","volume":"34","author":"D Popov","year":"1997","unstructured":"Popov D, Hasu M, Costache G, Stern D, Simionescu M. Capillary and aortic endothelia interact in situ with nonenzymatically glycated albumin and develop specific alterations in early experimental Diabetes. Acta Diabetol. 1997;34(4):285\u201393.","journal-title":"Acta Diabetol"},{"issue":"7","key":"2056_CR83","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0954-6111(97)90254-7","volume":"91","author":"K Watanabe","year":"1997","unstructured":"Watanabe K, Senju S, Toyoshima H, Yoshida M. Thickness of the basement membrane of bronchial epithelial cells in lung Diseases as determined by transbronchial biopsy. Respir Med. 1997;91(7):406\u201310.","journal-title":"Respir Med"},{"issue":"9","key":"2056_CR84","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1464-5491.2010.03073.x","volume":"27","author":"OL Klein","year":"2010","unstructured":"Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and type 2 Diabetes Mellitus. Diabet Med. 2010;27(9):977\u201387.","journal-title":"Diabet Med"},{"issue":"2","key":"2056_CR85","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1378\/chest.09-2622","volume":"138","author":"B van den Borst","year":"2010","unstructured":"van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in Diabetes: a metaanalysis. Chest. 2010;138(2):393\u2013406.","journal-title":"Chest"},{"issue":"7","key":"2056_CR86","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/1573399815666190716130324","volume":"16","author":"M Saini","year":"2020","unstructured":"Saini M, Kulandaivelan S, Bansal VK, Saini V, Sharma S, Kaur J, et al. Pulmonary Pathology among patients with type 2 Diabetes Mellitus: an updated systematic review and Meta-analysis. Curr Diabetes Rev. 2020;16(7):759\u201369.","journal-title":"Curr Diabetes Rev"},{"key":"2056_CR87","doi-asserted-by":"publisher","first-page":"106991","DOI":"10.1016\/j.rmed.2022.106991","volume":"203","author":"J D\u00edez-Manglano","year":"2022","unstructured":"D\u00edez-Manglano J, As\u00ecn Samper U. Type-1 Diabetes and pulmonary function tests. A meta-analysis. Respir Med. 2022;203:106991.","journal-title":"Respir Med"},{"issue":"1","key":"2056_CR88","doi-asserted-by":"publisher","first-page":"00371","DOI":"10.1183\/23120541.00371-2020","volume":"7","author":"J D\u00edez-Manglano","year":"2021","unstructured":"D\u00edez-Manglano J, Samper UA. Pulmonary function tests in type 2 Diabetes: a meta-analysis. ERJ Open Research. 2021;7(1):00371\u20132020.","journal-title":"ERJ Open Research"},{"issue":"2","key":"2056_CR89","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1479972307086313","volume":"5","author":"A Kaparianos","year":"2008","unstructured":"Kaparianos A, Argyropoulou E, Sampsonas F, Karkoulias K, Tsiamita M, Spiropoulos K. Pulmonary Complications in Diabetes Mellitus. Chron Respir Dis. 2008;5(2):101\u20138.","journal-title":"Chron Respir Dis"},{"issue":"1","key":"2056_CR90","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12890-022-02208-3","volume":"22","author":"W Li","year":"2022","unstructured":"Li W, Ning Y, Ma Y, Lin X, Man S, Wang B, et al. Association of lung function and blood glucose level: a 10-year study in China. BMC Pulm Med. 2022;22(1):444.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"2056_CR91","first-page":"e35081","volume":"15","author":"S Rajput","year":"2023","unstructured":"Rajput S, Parashar R, Sharma JP, Raghuwanshi P, Pakhare AP, Joshi R, et al. Assessment of Pulmonary functions and dysfunctions in type II Diabetes Mellitus: a comparative cross-sectional study. Cureus. 2023;15(2):e35081.","journal-title":"Cureus"},{"key":"2056_CR92","doi-asserted-by":"crossref","unstructured":"Maan HB, Meo SA, Al Rouq F, Meo IMU, Gacuan ME, Alkhalifah JM. Effect of Glycated Hemoglobin (HbA1c) and duration of Disease on Lung functions in type 2 Diabetic patients. Int J Environ Res Public Health. 2021;18(13).","DOI":"10.3390\/ijerph18136970"},{"key":"2056_CR93","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phrs.2018.10.008","volume":"137","author":"D Visca","year":"2018","unstructured":"Visca D, Pignatti P, Spanevello A, Lucini E, La Rocca E. Relationship between Diabetes and Respiratory Diseases\u2014clinical and therapeutic aspects. Pharmacol Res. 2018;137:230\u20135.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2056_CR94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2337\/dc09-0880","volume":"33","author":"SF Ehrlich","year":"2010","unstructured":"Ehrlich SF, Quesenberry CP Jr., Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with Diabetes are at increased risk for Asthma, Chronic Obstructive Pulmonary Disease, pulmonary fibrosis, and Pneumonia but not Lung cancer. Diabetes Care. 2010;33(1):55\u201360.","journal-title":"Diabetes Care"},{"issue":"12","key":"2056_CR95","doi-asserted-by":"publisher","first-page":"e0261246","DOI":"10.1371\/journal.pone.0261246","volume":"16","author":"JR Foe-Essomba","year":"2021","unstructured":"Foe-Essomba JR, Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, Mbaga DS, Kengne-Nd\u00e9 C, et al. Diabetes Mellitus and Tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders. PLoS ONE. 2021;16(12):e0261246.","journal-title":"PLoS ONE"},{"key":"2056_CR96","doi-asserted-by":"crossref","unstructured":"Antonio-Arques V, Cayl\u00e0 JA, Real J, Moreno-Martinez A, Orcau \u00c0, Mauricio D et al. Glycemic control and the risk of Tuberculosis in patients with Diabetes: a cohort study in a Mediterranean city. Front Public Health. 2022;10.","DOI":"10.3389\/fpubh.2022.1017024"},{"key":"2056_CR97","doi-asserted-by":"crossref","unstructured":"Antonio-Arques V, Franch-Nadal J, Moreno-Martinez A, Real J, Orcau \u00c0, Mauricio D et al. Subjects with Diabetes Mellitus are at increased risk for developing Tuberculosis: a Cohort Study in an Inner-City District of Barcelona (Spain). Front Public Health. 2022;10.","DOI":"10.3389\/fpubh.2022.789952"},{"issue":"3","key":"2056_CR98","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10456-017-9541-1","volume":"20","author":"J Filipowska","year":"2017","unstructured":"Filipowska J, Tomaszewski KA, Nied\u017awiedzki \u0141, Walocha JA, Nied\u017awiedzki T. The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis. 2017;20(3):291\u2013302.","journal-title":"Angiogenesis"},{"issue":"4","key":"2056_CR99","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/ten.teb.2020.0154","volume":"27","author":"EJ Lee","year":"2021","unstructured":"Lee EJ, Jain M, Alimperti S. Bone microvasculature: stimulus for tissue function and regeneration. Tissue Eng Part B Rev. 2021;27(4):313\u201329.","journal-title":"Tissue Eng Part B Rev"},{"key":"2056_CR100","doi-asserted-by":"publisher","first-page":"5046953","DOI":"10.1155\/2017\/5046953","volume":"2017","author":"SK Ramasamy","year":"2017","unstructured":"Ramasamy SK. Structure and functions of blood vessels and vascular niches in bone. Stem Cells Int. 2017;2017:5046953.","journal-title":"Stem Cells Int"},{"issue":"1","key":"2056_CR101","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12018-019-09259-x","volume":"17","author":"RD Prisby","year":"2019","unstructured":"Prisby RD. The clinical relevance of the bone vascular system: age-related implications. Clin Rev Bone Miner Metab. 2019;17(1):48\u201362.","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"3","key":"2056_CR102","first-page":"e13820","volume":"13","author":"C Kumari","year":"2021","unstructured":"Kumari C, Yagoub G, Ashfaque M, Jawed S, Hamid P. Consequences of Diabetes Mellitus in Bone Health. Traditional Rev Cureus. 2021;13(3):e13820.","journal-title":"Traditional Rev Cureus"},{"issue":"3","key":"2056_CR103","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1759720X16687480","volume":"9","author":"V Sundararaghavan","year":"2017","unstructured":"Sundararaghavan V, Mazur MM, Evans B, Liu J, Ebraheim NA. Diabetes and bone health: latest evidence and clinical implications. Ther Adv Musculoskelet Dis. 2017;9(3):67\u201374.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"2056_CR104","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13300-020-00964-1","volume":"12","author":"C Romero-D\u00edaz","year":"2021","unstructured":"Romero-D\u00edaz C, Duarte-Montero D, Guti\u00e9rrez-Romero SA, Mendivil CO. Diabetes and bone fragility. Diabetes Ther. 2021;12(1):71\u201386.","journal-title":"Diabetes Ther"},{"issue":"10","key":"2056_CR105","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S2213-8587(17)30134-1","volume":"5","author":"VV Shanbhogue","year":"2017","unstructured":"Shanbhogue VV, Hansen S, Frost M, Brixen K, Hermann AP. Bone Disease in Diabetes: another manifestation of microvascular Disease? Lancet Diabetes Endocrinol. 2017;5(10):827\u201338.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2056_CR106","doi-asserted-by":"crossref","unstructured":"Cavati G, Pirrotta F, Merlotti D, Ceccarelli E, Calabrese M, Gennari L et al. Role of Advanced Glycation End-products and oxidative stress in type-2-diabetes-induced bone fragility and implications on fracture risk stratification. Antioxid (Basel). 2023;12(4).","DOI":"10.3390\/antiox12040928"},{"issue":"1","key":"2056_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11914-017-0341-8","volume":"15","author":"RJ Fajardo","year":"2017","unstructured":"Fajardo RJ. Is Diabetic skeletal fragility Associated with Microvascular Complications in Bone? Curr Osteoporos Rep. 2017;15(1):1\u20138.","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2056_CR108","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","volume":"30","author":"A Oikawa","year":"2010","unstructured":"Oikawa A, Siragusa M, Quaini F, Mangialardi G, Katare RG, Caporali A, et al. Diabetes Mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol. 2010;30(3):498\u2013508.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2056_CR109","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00125-019-4865-6","volume":"62","author":"G Mangialardi","year":"2019","unstructured":"Mangialardi G, Ferland-McCollough D, Maselli D, Santopaolo M, Cordaro A, Spinetti G, et al. Bone marrow pericyte dysfunction in individuals with type 2 Diabetes. Diabetologia. 2019;62(7):1275\u201390.","journal-title":"Diabetologia"},{"issue":"3","key":"2056_CR110","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/CIRCRESAHA.112.300598","volume":"112","author":"G Spinetti","year":"2013","unstructured":"Spinetti G, Cordella D, Fortunato O, Sangalli E, Losa S, Gotti A, et al. Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155\/FOXO3a signaling pathway. Circ Res. 2013;112(3):510\u201322.","journal-title":"Circ Res"},{"issue":"6","key":"2056_CR111","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00395-010-0109-0","volume":"105","author":"A Orlandi","year":"2010","unstructured":"Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher AM, Dimmeler S. Long-term Diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol. 2010;105(6):703\u201312.","journal-title":"Basic Res Cardiol"},{"key":"2056_CR112","doi-asserted-by":"publisher","first-page":"990457","DOI":"10.3389\/fimmu.2022.990457","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen Y, Zhang Y, Zhou Z, Wang J, Han D, Sun J, et al. Dysfunction of macrophages leads to diabetic bone regeneration deficiency. Front Immunol. 2022;13:990457.","journal-title":"Front Immunol"},{"issue":"10","key":"2056_CR113","doi-asserted-by":"publisher","first-page":"e11001","DOI":"10.1016\/j.heliyon.2022.e11001","volume":"8","author":"J Zhao","year":"2022","unstructured":"Zhao J, Liang G, Luo M, Yang W, Xu N, Luo M, et al. Influence of type 2 Diabetes microangiopathy on bone mineral density and bone metabolism: a meta-analysis. Heliyon. 2022;8(10):e11001.","journal-title":"Heliyon"},{"issue":"5","key":"2056_CR114","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0192623318779565","volume":"46","author":"A Varela","year":"2018","unstructured":"Varela A, Jolette J. Bone toolbox: biomarkers, Imaging Tools, Biomechanics, and Histomorphometry. Toxicol Pathol. 2018;46(5):511\u201329.","journal-title":"Toxicol Pathol"},{"key":"2056_CR115","doi-asserted-by":"crossref","unstructured":"Murray CE, Coleman CM. Impact of Diabetes Mellitus on Bone Health. Int J Mol Sci. 2019;20(19).","DOI":"10.3390\/ijms20194873"},{"issue":"5","key":"2056_CR116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11914-022-00740-z","volume":"20","author":"M Tanios","year":"2022","unstructured":"Tanios M, Brickman B, Cage E, Abbas K, Smith C, Atallah M, et al. Diabetes and impaired fracture Healing: a narrative review of recent literature. Curr Osteoporos Rep. 2022;20(5):229\u201339.","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"2056_CR117","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 Diabetes Mellitus and Risk of Fracture. Am J Epidemiol. 2007;166(5):495\u2013505.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"2056_CR118","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/dme.12734","volume":"32","author":"VN Shah","year":"2015","unstructured":"Shah VN, Shah CS, Snell-Bergeon JK. Type 1 Diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med. 2015;32(9):1134\u201342.","journal-title":"Diabet Med"},{"issue":"1","key":"2056_CR119","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00198-015-3279-7","volume":"27","author":"Y Fan","year":"2016","unstructured":"Fan Y, Wei F, Lang Y, Liu Y. Diabetes Mellitus and risk of hip fractures: a meta-analysis. Osteoporos Int. 2016;27(1):219\u201328.","journal-title":"Osteoporos Int"},{"issue":"1","key":"2056_CR120","doi-asserted-by":"publisher","first-page":"e024067","DOI":"10.1136\/bmjopen-2018-024067","volume":"9","author":"W Hao","year":"2019","unstructured":"Hao W, Ying B, Qian X, Jian-Ling D. Diabetes Mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019;9(1):e024067.","journal-title":"BMJ Open"},{"issue":"1","key":"2056_CR121","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13098-021-00687-8","volume":"13","author":"J Dou","year":"2021","unstructured":"Dou J, Wang J, Zhang Q. Differences in the roles of types 1 and 2 Diabetes in the susceptibility to the risk of fracture: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):84.","journal-title":"Diabetol Metab Syndr"},{"key":"2056_CR122","doi-asserted-by":"publisher","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","volume":"137","author":"T Vilaca","year":"2020","unstructured":"Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, et al. The risk of hip and non-vertebral fractures in type 1 and type 2 Diabetes: a systematic review and meta-analysis update. Bone. 2020;137:115457.","journal-title":"Bone"},{"issue":"3","key":"2056_CR123","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.diabet.2007.10.008","volume":"34","author":"A R\u00e4kel","year":"2008","unstructured":"R\u00e4kel A, Sheehy O, Rahme E, LeLorier J. Osteoporosis among patients with type 1 and type 2 Diabetes. Diabetes Metab. 2008;34(3):193\u2013205.","journal-title":"Diabetes Metab"},{"issue":"4","key":"2056_CR124","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporos Int. 2007;18(4):427\u201344.","journal-title":"Osteoporos Int"},{"issue":"9","key":"2056_CR125","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00198-021-05934-2","volume":"32","author":"K Hidayat","year":"2021","unstructured":"Hidayat K, Fang QL, Shi BM, Qin LQ. Influence of glycemic control and hypoglycemia on the risk of fracture in patients with Diabetes Mellitus: a systematic review and meta-analysis of observational studies. Osteoporos Int. 2021;32(9):1693\u2013704.","journal-title":"Osteoporos Int"},{"issue":"1","key":"2056_CR126","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1038\/s41598-017-03748-z","volume":"7","author":"E Losada-Grande","year":"2017","unstructured":"Losada-Grande E, Hawley S, Soldevila B, Martinez-Laguna D, Nogues X, Diez-Perez A, et al. Insulin use and excess fracture risk in patients with type 2 Diabetes: a propensity-matched cohort analysis. Sci Rep. 2017;7(1):3781.","journal-title":"Sci Rep"},{"issue":"7\u20138","key":"2056_CR127","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/ans.15878","volume":"90","author":"ZC Ding","year":"2020","unstructured":"Ding ZC, Zeng WN, Rong X, Liang ZM, Zhou ZK. Do patients with Diabetes have an increased risk of impaired fracture healing? A systematic review and meta-analysis. ANZ J Surg. 2020;90(7\u20138):1259\u201364.","journal-title":"ANZ J Surg"},{"issue":"2","key":"2056_CR128","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.injury.2017.11.006","volume":"49","author":"H Gortler","year":"2018","unstructured":"Gortler H, Rusyn J, Godbout C, Chahal J, Schemitsch EH, Nauth A. Diabetes and Healing outcomes in Lower Extremity fractures: a systematic review. Injury. 2018;49(2):177\u201383.","journal-title":"Injury"},{"key":"2056_CR129","doi-asserted-by":"crossref","unstructured":"Braverman IM. The Cutaneous Microcirculation. Journal of Investigative Dermatology Symposium Proceedings. 2000;5(1):3\u20139.","DOI":"10.1046\/j.1087-0024.2000.00010.x"},{"key":"2056_CR130","doi-asserted-by":"crossref","unstructured":"Cracowski J-L, Roustit M. Human skin microcirculation. In: Compr Physiol 2020: 1105\u201354.","DOI":"10.1002\/cphy.c190008"},{"issue":"5","key":"2056_CR131","first-page":"e38961","volume":"15","author":"P David","year":"2023","unstructured":"David P, Singh S, Ankar R. A comprehensive overview of skin Complications in Diabetes and their Prevention. Cureus. 2023;15(5):e38961.","journal-title":"Cureus"},{"issue":"3","key":"2056_CR132","doi-asserted-by":"publisher","first-page":"e200921196637","DOI":"10.2174\/1573399817666210920102318","volume":"18","author":"L Legiawati","year":"2022","unstructured":"Legiawati L. The role of oxidative stress, inflammation, and Advanced Glycation End product in skin manifestations of Diabetes Mellitus. Curr Diabetes Rev. 2022;18(3):e200921196637.","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"2056_CR133","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13098-016-0176-y","volume":"8","author":"GMC de Macedo","year":"2016","unstructured":"de Macedo GMC, Nunes S, Barreto T. Skin disorders in Diabetes Mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr. 2016;8(1):63.","journal-title":"Diabetol Metab Syndr"},{"issue":"8","key":"2056_CR134","doi-asserted-by":"publisher","first-page":"108552","DOI":"10.1016\/j.jdiacomp.2023.108552","volume":"37","author":"AD Mooradian","year":"2023","unstructured":"Mooradian AD. Diabetes-related perturbations in the integrity of physiologic barriers. J Diabetes Complications. 2023;37(8):108552.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"2056_CR135","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/00128071-200506040-00003","volume":"6","author":"BT Ngo","year":"2005","unstructured":"Ngo BT, Hayes KD, DiMiao DJ, Srinivasan SK, Huerter CJ, Rendell MS. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol. 2005;6(4):225\u201337.","journal-title":"Am J Clin Dermatol"},{"key":"2056_CR136","doi-asserted-by":"crossref","unstructured":"Sern\u00e9 EH, Stehouwer CD, ter Maaten JC, ter, Wee PM, Rauwerda JA, Donker AJ et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation. 1999;99(7):896\u2013902.","DOI":"10.1161\/01.CIR.99.7.896"},{"issue":"5","key":"2056_CR137","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2337\/diabetes.51.5.1515","volume":"51","author":"EH Sern\u00e9","year":"2002","unstructured":"Sern\u00e9 EH, Ijzerman RG, Gans ROB, Nijveldt R, de Vries G, Evertz R, et al. Direct evidence for insulin-Induced Capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia. Diabetes. 2002;51(5):1515\u201322.","journal-title":"Diabetes"},{"issue":"2","key":"2056_CR138","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mvr.2006.11.004","volume":"73","author":"E Tibiri\u00e7\u00e1","year":"2007","unstructured":"Tibiri\u00e7\u00e1 E, Rodrigues E, Cobas RA, Gomes MB. Endothelial function in patients with type 1 Diabetes evaluated by skin capillary recruitment. Microvasc Res. 2007;73(2):107\u201312.","journal-title":"Microvasc Res"},{"issue":"7","key":"2056_CR139","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2337\/diab.44.7.721","volume":"44","author":"JE Tooke","year":"1995","unstructured":"Tooke JE. Microvascular function in human Diabetes. A physiological perspective. Diabetes. 1995;44(7):721\u20136.","journal-title":"Diabetes"},{"key":"2056_CR140","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0168-8227(96)01240-5","volume":"31","author":"JE Tooke","year":"1996","unstructured":"Tooke JE, Morris SJ, Shore AC. Microvascular functional abnormalities in Diabetes: the role of the endothelium. Diabetes Res Clin Pract. 1996;31:127\u2013S32.","journal-title":"Diabetes Res Clin Pract"},{"issue":"52","key":"2056_CR141","doi-asserted-by":"publisher","first-page":"e5714","DOI":"10.1097\/MD.0000000000005714","volume":"95","author":"P-C Hsu","year":"2016","unstructured":"Hsu P-C, Liao P-Y, Chang H-H, Chiang JY, Huang Y-C, Lo L-C. Nailfold capillary abnormalities are associated with type 2 Diabetes progression and correlated with peripheral neuropathy. Med (Baltim). 2016;95(52):e5714.","journal-title":"Med (Baltim)"},{"key":"2056_CR142","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-3-319-91287-5_58","volume":"1072","author":"G Lisco","year":"2018","unstructured":"Lisco G, Cicco G, Cignarelli A, Garruti G, Laviola L, Giorgino F. Computerized video-capillaroscopy alteration related to Diabetes Mellitus and its Complications. Adv Exp Med Biol. 2018;1072:363\u20138.","journal-title":"Adv Exp Med Biol"},{"key":"2056_CR143","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mvr.2017.03.001","volume":"112","author":"G Maldonado","year":"2017","unstructured":"Maldonado G, Guerrero R, Paredes C, R\u00edos C. Nailfold capillaroscopy in Diabetes Mellitus. Microvasc Res. 2017;112:41\u20136.","journal-title":"Microvasc Res"},{"key":"2056_CR144","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4236\/ojpathology.2015.52010","volume":"5","author":"A Rajaei","year":"2015","unstructured":"Rajaei A, Dehghan P, Farahani Z. Nailfold Capillaroscopy findings in Diabetic patients (a pilot cross-sectional study). Open J Pathol. 2015;5:65\u201372.","journal-title":"Open J Pathol"},{"issue":"18","key":"2056_CR145","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.023446","volume":"134","author":"BM S\u00f6rensen","year":"2016","unstructured":"S\u00f6rensen BM, Houben AJ, Berendschot TT, Schouten JS, Kroon AA, van der Kallen CJ, et al. Prediabetes and type 2 Diabetes are Associated with generalized microvascular dysfunction: the Maastricht Study. Circulation. 2016;134(18):1339\u201352.","journal-title":"Circulation"},{"issue":"4","key":"2056_CR146","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jdiacomp.2016.12.007","volume":"31","author":"AS de Matheus","year":"2017","unstructured":"de Matheus AS, Clemente EL, de Lourdes Guimar\u00e3es Rodrigues M, Torres Valen\u00e7a DC, Gomes MB. Assessment of microvascular endothelial function in type 1 Diabetes using laser speckle contrast imaging. J Diabetes Complications. 2017;31(4):753\u20137.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"2056_CR147","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-016-0487-1","volume":"16","author":"D Fuchs","year":"2017","unstructured":"Fuchs D, Dupon PP, Schaap LA, Draijer R. The association between Diabetes and dermal microvascular dysfunction non-invasively assessed by laser doppler with local thermal hyperemia: a systematic review with meta-analysis. Cardiovasc Diabetol. 2017;16(1):11.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2056_CR148","doi-asserted-by":"publisher","first-page":"95","DOI":"10.15277\/bjdvd.2014.027","volume":"14","author":"AMC George","year":"2014","unstructured":"George AMC. Diabetic Dermopathy. Br J Diabetes Vasc Dis. 2014;14(3):95\u20137.","journal-title":"Br J Diabetes Vasc Dis"},{"key":"2056_CR149","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.2147\/DMSO.S286887","volume":"13","author":"PP Naik","year":"2020","unstructured":"Naik PP, Farrukh SN. Clinical significance of Diabetic Dermatopathy. Diabetes Metab Syndr Obes. 2020;13:4823\u20137.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2056_CR150","unstructured":"Labib A, Rosen J, Yosipovitch G. Skin Manifestations of Diabetes Mellitus. In: Endotext Edited by Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J South Dartmouth (MA); 2000."},{"issue":"1","key":"2056_CR151","first-page":"50","volume":"13","author":"UF Haustein","year":"1999","unstructured":"Haustein UF. Scleroderma-like lesions in insulin-dependent Diabetes Mellitus. J Eur Acad Dermatol Venereol. 1999;13(1):50\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"2056_CR152","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","volume":"53","author":"C Ferreli","year":"2017","unstructured":"Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous manifestations of Scleroderma and Scleroderma-Like disorders: a Comprehensive Review. Clin Rev Allergy Immunol. 2017;53(3):306\u201336.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"2056_CR153","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jaad.2013.05.034","volume":"69","author":"SD Reid","year":"2013","unstructured":"Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013;69(5):783\u201391.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2056_CR154","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1046\/j.1365-4362.2000.00947.x","volume":"39","author":"BA Lipsky","year":"2000","unstructured":"Lipsky BA, Baker PD, Ahroni JH. Diabetic bullae: 12 cases of a purportedly rare cutaneous disorder. Int J Dermatol. 2000;39(3):196\u2013200.","journal-title":"Int J Dermatol"},{"key":"2056_CR155","doi-asserted-by":"crossref","unstructured":"Owusu J, Barrett E. Early microvascular dysfunction: is the Vasa Vasorum a missing link in insulin resistance and Atherosclerosis. Int J Mol Sci 2021;22(14).","DOI":"10.3390\/ijms22147574"},{"issue":"2","key":"2056_CR156","doi-asserted-by":"publisher","first-page":"H295","DOI":"10.1152\/ajpheart.00884.2009","volume":"298","author":"MJ Mulligan-Kehoe","year":"2010","unstructured":"Mulligan-Kehoe MJ. The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol. 2010;298(2):H295\u2013305.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"16","key":"2056_CR157","doi-asserted-by":"publisher","first-page":"eabl6364","DOI":"10.1126\/sciadv.abl6364","volume":"8","author":"JA Phillippi","year":"2022","unstructured":"Phillippi JA. On vasa vasorum: a history of advances in understanding the vessels of vessels. Sci Adv. 2022;8(16):eabl6364.","journal-title":"Sci Adv"},{"issue":"4","key":"2056_CR158","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cardiores.2007.06.020","volume":"75","author":"EL Ritman","year":"2007","unstructured":"Ritman EL, Lerman A. The dynamic vasa vasorum. Cardiovasc Res. 2007;75(4):649\u201358.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2056_CR159","first-page":"431","volume":"29","author":"L Angervall","year":"1966","unstructured":"Angervall L, Dahl I, S\u00e4ve-S\u00f6derbergh J. The aortic vasa vasorum in juvenile Diabetes. Pathol Microbiol (Basel). 1966;29(4):431\u20137.","journal-title":"Pathol Microbiol (Basel)"},{"issue":"2","key":"2056_CR160","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2015.05.024","volume":"241","author":"E Rubinat","year":"2015","unstructured":"Rubinat E, Ortega E, Traveset A, Arcidiacono MV, Alonso N, Betriu A, et al. Microangiopathy of common carotid vasa vasorum in type 1 Diabetes Mellitus. Atherosclerosis. 2015;241(2):334\u20138.","journal-title":"Atherosclerosis"},{"issue":"2","key":"2056_CR161","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/echo.12646","volume":"32","author":"UK Sampson","year":"2015","unstructured":"Sampson UK, Harrell FE Jr., Fazio S, Nwosu S, Mercaldo N, Mensah GA, et al. Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population. Echocardiography. 2015;32(2):264\u201370.","journal-title":"Echocardiography"},{"issue":"1","key":"2056_CR162","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2013.02.011","volume":"228","author":"MV Arcidiacono","year":"2013","unstructured":"Arcidiacono MV, Traveset A, Rubinat E, Ortega E, Betriu A, Hernandez M, et al. Microangiopathy of large artery wall: a neglected complication of Diabetes Mellitus. Atherosclerosis. 2013;228(1):142\u20137.","journal-title":"Atherosclerosis"},{"issue":"5","key":"2056_CR163","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2337\/dc18-2483","volume":"42","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Nair V, Chaube R, Stoute H, Werstuck G. Dysglycemia and the density of the coronary Vasa Vasorum. Diabetes Care. 2019;42(5):980\u20132.","journal-title":"Diabetes Care"},{"issue":"2","key":"2056_CR164","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1358863X11402249","volume":"16","author":"KR Purushothaman","year":"2011","unstructured":"Purushothaman KR, Purushothaman M, Muntner P, Lento PA, O\u2019Connor WN, Sharma SK, et al. Inflammation, neovascularization and intra-plaque Hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic Atherosclerosis. Vasc Med. 2011;16(2):103\u20138.","journal-title":"Vasc Med"},{"issue":"13","key":"2056_CR165","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/cvr\/cvy174","volume":"114","author":"J Raffort","year":"2018","unstructured":"Raffort J, Lareyre F, Cl\u00e9ment M, Hassen-Khodja R, Chinetti G, Mallat Z. Diabetes and aortic Aneurysm: current state of the art. Cardiovasc Res. 2018;114(13):1702\u201313.","journal-title":"Cardiovasc Res"},{"key":"2056_CR166","doi-asserted-by":"publisher","first-page":"1112430","DOI":"10.3389\/fcvm.2023.1112430","volume":"10","author":"B Picatoste","year":"2023","unstructured":"Picatoste B, Cerro-Pardo I, Blanco-Colio LM, Mart\u00edn-Ventura JL. Protection of Diabetes in aortic abdominal Aneurysm: are antidiabetics the real effectors? Front Cardiovasc Med. 2023;10:1112430.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"2056_CR167","doi-asserted-by":"publisher","first-page":"e3159","DOI":"10.1002\/dmrr.3159","volume":"35","author":"L Fuso","year":"2019","unstructured":"Fuso L, Pitocco D, Antonelli-Incalzi R. Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary Hypertension. Diabetes Metab Res Rev. 2019;35(6):e3159.","journal-title":"Diabetes Metab Res Rev"},{"issue":"13","key":"2056_CR168","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","volume":"78","author":"MG Del Buono","year":"2021","unstructured":"Del Buono MG, Montone RA, Camilli M, Carbone S, Narula J, Lavie CJ, et al. Coronary microvascular dysfunction across the Spectrum of Cardiovascular Diseases: JACC State-of-the-art review. J Am Coll Cardiol. 2021;78(13):1352\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"2056_CR169","doi-asserted-by":"crossref","unstructured":"Fonseca DA, Antunes PE, Cotrim M-D. The Morphology, Physiology and Pathophysiology of Coronary Microcirculation. In: Microcirculation Revisited Edited by Helena L. Rijeka: IntechOpen; 2016: Ch. 2.","DOI":"10.5772\/64537"},{"issue":"6","key":"2056_CR170","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1177\/0300060516675504","volume":"45","author":"A Kibel","year":"2017","unstructured":"Kibel A, Selthofer-Relatic K, Drenjancevic I, Bacun T, Bosnjak I, Kibel D, et al. Coronary microvascular dysfunction in Diabetes Mellitus. J Int Med Res. 2017;45(6):1901\u201329.","journal-title":"J Int Med Res"},{"key":"2056_CR171","doi-asserted-by":"crossref","unstructured":"Zhang Z, Li X, He J, Wang S, Wang J, Liu J et al. Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction. J Thromb Thrombolysis. 2023.","DOI":"10.1007\/s11239-023-02862-2"},{"key":"2056_CR172","doi-asserted-by":"crossref","unstructured":"Sorop O, van de Wouw J, Merkus D, Duncker DJ. Coronary Microvascular Dysfunction in Cardiovascular Disease: Lessons from Large Animal Models. In: Microcirculation: From Bench to Bedside Edited by Dorobantu M, Badimon L. Cham: Springer International Publishing; 2020: 21\u201343.","DOI":"10.1007\/978-3-030-28199-1_2"},{"key":"2056_CR173","doi-asserted-by":"crossref","unstructured":"Vancheri F, Longo G, Vancheri S, Henein M. Coronary microvascular dysfunction. J Clin Med. 2020;9(9).","DOI":"10.3390\/jcm9092880"},{"key":"2056_CR174","doi-asserted-by":"publisher","first-page":"731059","DOI":"10.3389\/fcvm.2022.731059","volume":"9","author":"B Fu","year":"2022","unstructured":"Fu B, Wei X, Lin Y, Chen J, Yu D. Pathophysiologic basis and diagnostic approaches for Ischemia with non-obstructive coronary arteries: a Literature Review. Front Cardiovasc Med. 2022;9:731059.","journal-title":"Front Cardiovasc Med"},{"key":"2056_CR175","doi-asserted-by":"crossref","unstructured":"Beare JE, Curtis-Whitchurch L, LeBlanc AJ, Hoying JB. Microvasculature in Health and Disease. In: Encyclopedia of Cardiovascular Research and Medicine Edited by Vasan RS, Sawyer DB. Oxford: Elsevier; 2018: 349 \u2013 64.","DOI":"10.1016\/B978-0-12-809657-4.99820-X"},{"issue":"4","key":"2056_CR176","doi-asserted-by":"publisher","first-page":"H1404","DOI":"10.1152\/ajpheart.00235.2003","volume":"285","author":"Z Bagi","year":"2003","unstructured":"Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in type 2 Diabetes Mellitus. Am J Physiol Heart Circ Physiol. 2003;285(4):H1404\u201310.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"2056_CR177","first-page":"421","volume":"84","author":"T Ledet","year":"1976","unstructured":"Ledet T. Diabetic cardiopathy. Quantitative histological studies of the heart from young juvenile diabetics. Acta Pathol Microbiol Scand A. 1976;84(5):421\u20138.","journal-title":"Acta Pathol Microbiol Scand A"},{"issue":"5","key":"2056_CR178","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/BF01309899","volume":"4","author":"T Ledet","year":"1968","unstructured":"Ledet T. Histological and histochemical changes in the coronary arteries of old diabetic patients. Diabetologia. 1968;4(5):268\u201372.","journal-title":"Diabetologia"},{"issue":"2","key":"2056_CR179","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0002-9343(78)90049-9","volume":"64","author":"FV Crall Jr","year":"1978","unstructured":"Crall FV Jr., Roberts WC. The extramural and intramural coronary arteries in juvenile Diabetes Mellitus: analysis of nine necropsy patients aged 19 to 38 years with onset of Diabetes before age 15 years. Am J Med. 1978;64(2):221\u201330.","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"2056_CR180","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2337\/diab.46.2.S119","volume":"46","author":"BE Strauer","year":"1997","unstructured":"Strauer BE, Motz W, Vogt M, Schwartzkopff B. Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes. 1997;46(Suppl 2):119\u201324.","journal-title":"Diabetes"},{"issue":"1","key":"2056_CR181","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0029-1211722","volume":"105","author":"BE Strauer","year":"1997","unstructured":"Strauer BE, Motz W, Vogt M, Schwartzkopff B. Evidence for reduced coronary flow reserve in patients with insulin-dependent Diabetes. A possible cause for diabetic Heart Disease in man. Exp Clin Endocrinol Diabetes. 1997;105(1):15\u201320.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2056_CR182","doi-asserted-by":"publisher","first-page":"765071","DOI":"10.3389\/fcvm.2021.765071","volume":"8","author":"E Gallinoro","year":"2021","unstructured":"Gallinoro E, Paolisso P, Candreva A, Bermpeis K, Fabbricatore D, Esposito G, et al. Microvascular dysfunction in patients with type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve. Front Cardiovasc Med. 2021;8:765071.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2056_CR183","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/01.RES.0000052671.53256.49","volume":"92","author":"H Miura","year":"2003","unstructured":"Miura H, Wachtel RE, Loberiza FR Jr., Saito T, Miura M, Nicolosi AC, et al. Diabetes Mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res. 2003;92(2):151\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"2056_CR184","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12968-017-0397-8","volume":"19","author":"E Levelt","year":"2017","unstructured":"Levelt E, Piechnik SK, Liu A, Wijesurendra RS, Mahmod M, Ariga R, et al. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 Diabetes Mellitus without obstructive coronary artery Disease. J Cardiovasc Magn Reson. 2017;19(1):81.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7","key":"2056_CR185","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/diab.42.7.1017","volume":"42","author":"A Nitenberg","year":"1993","unstructured":"Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali J-R. Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic patients with Angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 1993;42(7):1017\u201325.","journal-title":"Diabetes"},{"issue":"3","key":"2056_CR186","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/01.CIR.91.3.635","volume":"91","author":"PJ Nahser","year":"1995","unstructured":"Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary Flow Reserve and metabolic coronary vasodilation in patients with Diabetes Mellitus. Circulation. 1995;91(3):635\u201340.","journal-title":"Circulation"},{"key":"2056_CR187","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","volume":"250","author":"P Ong","year":"2018","unstructured":"Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018;250:16\u201320.","journal-title":"Int J Cardiol"},{"issue":"8","key":"2056_CR188","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830\u201340.","journal-title":"N Engl J Med"},{"issue":"4","key":"2056_CR189","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s12350-022-02974-x","volume":"29","author":"C Bradley","year":"2022","unstructured":"Bradley C, Berry C. Definition and epidemiology of coronary microvascular Disease. J Nucl Cardiol. 2022;29(4):1763\u201375.","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"2056_CR190","doi-asserted-by":"publisher","first-page":"e023207","DOI":"10.1161\/JAHA.121.023207","volume":"11","author":"N Mileva","year":"2022","unstructured":"Mileva N, Nagumo S, Mizukami T, Sonck J, Berry C, Gallinoro E, et al. Prevalence of coronary microvascular Disease and coronary vasospasm in patients with nonobstructive coronary artery Disease: systematic review and Meta-analysis. J Am Heart Assoc. 2022;11(7):e023207.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"2056_CR191","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2169\/internalmedicine.6158-20","volume":"60","author":"T Nishi","year":"2021","unstructured":"Nishi T, Saito Y, Kitahara H, Nishi T, Fujimoto Y, Kobayashi Y. Coronary Flow Reserve and Glycemic Variability in patients with coronary artery Disease. Intern Med. 2021;60(8):1151\u20138.","journal-title":"Intern Med"},{"issue":"1","key":"2056_CR192","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-019-0833-1","volume":"18","author":"JD Sara","year":"2019","unstructured":"Sara JD, Taher R, Kolluri N, Vella A, Lerman LO, Lerman A. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery Disease. Cardiovasc Diabetol. 2019;18(1):22.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2056_CR193","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0735-1097(97)00327-6","volume":"30","author":"I Yokoyama","year":"1997","unstructured":"Yokoyama I, Momomura S-i, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, et al. Reduced myocardial Flow Reserve in non\u2013insulin-dependent Diabetes Mellitus. J Am Coll Cardiol. 1997;30(6):1472\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"6808","key":"2056_CR194","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0140-6736(54)90924-1","volume":"266","author":"K Lundbaek","year":"1954","unstructured":"Lundbaek K. Diabetic Angiopathy: a specific vascular Disease. Lancet. 1954;266(6808):377\u20139.","journal-title":"Lancet"},{"issue":"12","key":"2056_CR195","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.2337\/dci22-0032","volume":"45","author":"B Trimarco","year":"2022","unstructured":"Trimarco B, Barbato E, Izzo R, Morisco C. Microvascular Disease and the Pathogenesis of Heart Failure in Diabetes: a tiny piece of the tricky puzzle. Diabetes Care. 2022;45(12):2817\u20139.","journal-title":"Diabetes Care"},{"issue":"1","key":"2056_CR196","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","volume":"124","author":"HC Kenny","year":"2019","unstructured":"Kenny HC, Abel ED. Heart Failure in type 2 Diabetes Mellitus. Circ Res. 2019;124(1):121\u201341.","journal-title":"Circ Res"},{"issue":"4","key":"2056_CR197","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0975-3583.89805","volume":"2","author":"VC Patil","year":"2011","unstructured":"Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P. Diastolic dysfunction in asymptomatic type 2 Diabetes Mellitus with normal systolic function. J Cardiovasc Dis Res. 2011;2(4):213\u201322.","journal-title":"J Cardiovasc Dis Res"},{"issue":"4","key":"2056_CR198","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"key":"2056_CR199","doi-asserted-by":"publisher","first-page":"1032268","DOI":"10.3389\/fendo.2022.1032268","volume":"13","author":"X Zhao","year":"2022","unstructured":"Zhao X, Liu S, Wang X, Chen Y, Pang P, Yang Q, et al. Diabetic cardiomyopathy: clinical phenotype and practice. Front Endocrinol (Lausanne). 2022;13:1032268.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2056_CR200","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"3","key":"2056_CR201","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10741-021-10200-y","volume":"28","author":"FR Prandi","year":"2023","unstructured":"Prandi FR, Evangelista I, Sergi D, Palazzuoli A, Romeo F. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants. Heart Fail Rev. 2023;28(3):597\u2013606.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2056_CR202","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2337\/dc17-0755","volume":"41","author":"PB Sandesara","year":"2018","unstructured":"Sandesara PB, O\u2019Neal WT, Kelli HM, Samman-Tahhan A, Hammadah M, Quyyumi AA, et al. The Prognostic significance of Diabetes and microvascular Complications in patients with Heart Failure with preserved ejection fraction. Diabetes Care. 2018;41(1):150\u20135.","journal-title":"Diabetes Care"},{"issue":"9","key":"2056_CR203","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.2337\/dc18-2515","volume":"42","author":"J Tromp","year":"2019","unstructured":"Tromp J, Lim SL, Tay WT, Teng TK, Chandramouli C, Ouwerkerk W, et al. Microvascular Disease in patients with Diabetes with Heart Failure and reduced ejection Versus Preserved Ejection Fraction. Diabetes Care. 2019;42(9):1792\u20139.","journal-title":"Diabetes Care"},{"issue":"12","key":"2056_CR204","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/dc22-0177","volume":"45","author":"FR Li","year":"2022","unstructured":"Li FR, Hukportie DN, Yang J, Yang HH, Chen GC, Wu XB. Microvascular burden and Incident Heart Failure among Middle-aged and older adults with type 1 or type 2 Diabetes. Diabetes Care. 2022;45(12):2999\u20133006.","journal-title":"Diabetes Care"},{"issue":"2","key":"2056_CR205","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jacc.2016.10.058","volume":"69","author":"R Hinkel","year":"2017","unstructured":"Hinkel R, Howe A, Renner S, Ng J, Lee S, Klett K, et al. Diabetes Mellitus-Induced Microvascular destabilization in the myocardium. J Am Coll Cardiol. 2017;69(2):131\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"2056_CR206","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","volume":"36","author":"PM Seferovi\u0107","year":"2015","unstructured":"Seferovi\u0107 PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced Disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36(27):1718\u201327.","journal-title":"Eur Heart J"},{"issue":"4","key":"2056_CR207","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for Heart Failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2056_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2017.07.012","volume":"6","author":"WJ Paulus","year":"2018","unstructured":"Paulus WJ, Dal Canto E. Distinct myocardial targets for Diabetes therapy in Heart Failure with preserved or reduced ejection fraction. JACC Heart Fail. 2018;6(1):1\u20137.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"2056_CR209","first-page":"277","volume":"16","author":"L Haywood","year":"2001","unstructured":"Haywood L, Walsh DA. Vasculature of the normal and arthritic synovial joint. Histol Histopathol. 2001;16(1):277\u201384.","journal-title":"Histol Histopathol"},{"issue":"6","key":"2056_CR210","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1152\/physiol.00026.2015","volume":"30","author":"C Latroche","year":"2015","unstructured":"Latroche C, Gitiaux C, Chr\u00e9tien F, Desguerre I, Mounier R, Chazaud B. Skeletal muscle microvasculature: a highly dynamic lifeline. Physiology. 2015;30(6):417\u201327.","journal-title":"Physiology"},{"key":"2056_CR211","unstructured":"Cathryn MK. The Skeletal Muscle Microvasculature and Its Effects on Metabolism. In: Microcirculation Revisited Edited by Helena L. Rijeka: IntechOpen; 2016: Ch. 3."},{"key":"2056_CR212","doi-asserted-by":"crossref","unstructured":"Abramson DI, Miller DS. Circulation to Joints and Associated Structures. In: Vascular Problems in Musculoskeletal Disorders of the Limbs Edited by Abramson DI, Miller DS. New York, NY: Springer New York; 1981: 41 \u2013 7.","DOI":"10.1007\/978-1-4612-5862-9_4"},{"key":"2056_CR213","doi-asserted-by":"crossref","unstructured":"Gupta V, Ezhilarasan Santhi SS, Ravi S, Ramanan EA. Rheumatological and Musculoskeletal Complications in Diabetes Patients. Journal of Endocrinology and Metabolism; Vol\u00a012, No 4\u20135, Oct 2022. 2022.","DOI":"10.14740\/jem811"},{"issue":"2","key":"2056_CR214","doi-asserted-by":"publisher","first-page":"63","DOI":"10.15406\/jdmdc.2020.07.00202","volume":"7","author":"S Ghosal","year":"2020","unstructured":"Ghosal S, Ghosal A. Diabetes and musculoskeletal disorders-a review. J Diabetes Metabolic Disorders Control. 2020;7(2):63\u201371.","journal-title":"J Diabetes Metabolic Disorders Control"},{"key":"2056_CR215","doi-asserted-by":"crossref","unstructured":"Csonka V, Varj\u00fa C, Lendvay M. Diabetes mellitus-related musculoskeletal disorders: unveiling the cluster of Diseases. Prim Care Diabetes. 2023.","DOI":"10.1016\/j.pcd.2023.08.003"},{"issue":"6","key":"2056_CR216","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3904\/kjim.2022.168","volume":"37","author":"JH Choi","year":"2022","unstructured":"Choi JH, Kim HR, Song KH. Musculoskeletal Complications in patients with Diabetes Mellitus. Korean J Intern Med. 2022;37(6):1099\u2013110.","journal-title":"Korean J Intern Med"},{"issue":"4","key":"2056_CR217","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5152\/eurjrheum.2018.18044","volume":"5","author":"T S\u00f6zen","year":"2018","unstructured":"S\u00f6zen T, Ba\u015faran N, T\u0131nazl\u0131 M, \u00d6z\u0131\u015f\u0131k L. Musculoskeletal problems in Diabetes Mellitus. Eur J Rheumatol. 2018;5(4):258\u201365.","journal-title":"Eur J Rheumatol"},{"issue":"9","key":"2056_CR218","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.4239\/wjd.v6.i9.1108","volume":"6","author":"EG Gerrits","year":"2015","unstructured":"Gerrits EG, Landman GW, Nijenhuis-Rosien L, Bilo HJ. Limited joint mobility syndrome in Diabetes Mellitus: a minireview. World J Diabetes. 2015;6(9):1108\u201312.","journal-title":"World J Diabetes"},{"issue":"8","key":"2056_CR219","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/dme.13955","volume":"36","author":"NE Hill","year":"2019","unstructured":"Hill NE, Roscoe D, Stacey MJ, Chew S. Cheiroarthropathy and tendinopathy in Diabetes. Diabet Med. 2019;36(8):939\u201347.","journal-title":"Diabet Med"},{"issue":"3","key":"2056_CR220","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/2141-9248.117942","volume":"3","author":"A Pandey","year":"2013","unstructured":"Pandey A, Usman K, Reddy H, Gutch M, Jain N, Qidwai S. Prevalence of hand disorders in type 2 Diabetes Mellitus and its correlation with microvascular Complications. Ann Med Health Sci Res. 2013;3(3):349\u201354.","journal-title":"Ann Med Health Sci Res"},{"issue":"3","key":"2056_CR221","first-page":"e36701","volume":"15","author":"A Paul","year":"2023","unstructured":"Paul A, Gnanamoorthy K. The Association of Diabetic Cheiroarthropathy with Microvascular Complications of type 2 Diabetes Mellitus: a cross-sectional study. Cureus. 2023;15(3):e36701.","journal-title":"Cureus"},{"issue":"6","key":"2056_CR222","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.berh.2003.11.001","volume":"17","author":"PET Arkkila","year":"2003","unstructured":"Arkkila PET, Gautier J-F. Musculoskeletal disorders in Diabetes Mellitus: an update. Best Pract Res Clin Rheumatol. 2003;17(6):945\u201370.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"2056_CR223","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF02742848","volume":"24","author":"M Vera","year":"1987","unstructured":"Vera M, Shumkov G, Guell R. Histological and histochemical skin changes in insulin-dependent diabetic patients with and without limited joint mobility. Acta Diabetologia Latina. 1987;24(2):101\u20138.","journal-title":"Acta Diabetologia Latina"},{"issue":"3","key":"2056_CR224","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/rheumatology\/28.3.195","volume":"28","author":"WS Mitchell","year":"1989","unstructured":"Mitchell WS, Winocour PH, Gush RJ, Taylor LJ, Baker RD, Anderson DC, et al. Skin blood flow and limited joint mobility in insulin-dependent Diabetes Mellitus. Br J Rheumatol. 1989;28(3):195\u2013200.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"2056_CR225","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13244-019-0768-9","volume":"10","author":"AB Rosskopf","year":"2019","unstructured":"Rosskopf AB, Loupatatzis C, Pfirrmann CWA, B\u00f6ni T, Berli MC. The Charcot foot: a pictorial review. Insights into Imaging. 2019;10(1):77.","journal-title":"Insights into Imaging"},{"key":"2056_CR226","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.jcte.2020.100239","volume":"22","author":"D Dardari","year":"2020","unstructured":"Dardari D. An overview of Charcot\u2019s neuroarthropathy. J Clin Translational Endocrinol. 2020;22:100239.","journal-title":"J Clin Translational Endocrinol"},{"issue":"8","key":"2056_CR227","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/1744666X.2020.1804869","volume":"16","author":"TH Yates","year":"2020","unstructured":"Yates TH, Cooperman SR, Shofler D, Agrawal DK. Current concepts underlying the pathophysiology of acute Charcot neuroarthropathy in the diabetic foot and ankle. Expert Rev Clin Immunol. 2020;16(8):839\u201345.","journal-title":"Expert Rev Clin Immunol"},{"key":"2056_CR228","doi-asserted-by":"crossref","unstructured":"Kaynak G, Birsel O, G\u00fcven MF, O\u011f\u00fct T. An overview of the Charcot foot pathophysiology. Diabet Foot Ankle. 2013;4.","DOI":"10.3402\/dfa.v4i0.21117"},{"issue":"1","key":"2056_CR229","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13047-022-00522-x","volume":"15","author":"SM Lanting","year":"2022","unstructured":"Lanting SM, Chan TL, Casey SL, Peterson BJ, Chuter VH. Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis. J Foot Ankle Res. 2022;15(1):17.","journal-title":"J Foot Ankle Res"},{"issue":"1","key":"2056_CR230","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2337\/diacare.26.1.211","volume":"26","author":"AJ Trujillo-Santos","year":"2003","unstructured":"Trujillo-Santos AJ. Diabetic muscle infarction: an underdiagnosed complication of long-standing Diabetes. Diabetes Care. 2003;26(1):211\u20135.","journal-title":"Diabetes Care"},{"key":"2056_CR231","unstructured":"2015;3(1):e000082."},{"issue":"6","key":"2056_CR232","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s10067-003-0789-z","volume":"22","author":"GS Habib","year":"2003","unstructured":"Habib GS, Nashashibi M, Saliba W, Haj S. Diabetic muscular infarction: emphasis on pathogenesis. Clin Rheumatol. 2003;22(6):450\u20131.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"2056_CR233","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2337\/diacare.9.6.623","volume":"9","author":"CS Chester","year":"1986","unstructured":"Chester CS, Banker BQ. Focal Infarction of Muscle in diabetics. Diabetes Care. 1986;9(6):623\u201330.","journal-title":"Diabetes Care"},{"key":"2056_CR234","doi-asserted-by":"crossref","unstructured":"Ganokroj P, Boonchaya-Anant P. Diabetic muscle infarction: rare complication with a distinct clinical manifestation. BMJ Case Rep. 2019;12(4).","DOI":"10.1136\/bcr-2018-228480"},{"key":"2056_CR235","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fphys.2020.00028","volume":"11","author":"O Baum","year":"2020","unstructured":"Baum O, Bernd J, Becker S, Odriozola A, Zuber B, Tschanz SA, et al. Structural microangiopathies in skeletal muscle related to systemic vascular pathologies in humans. Front Physiol. 2020;11:28.","journal-title":"Front Physiol"},{"issue":"Suppl 1","key":"2056_CR236","doi-asserted-by":"publisher","first-page":"e3268","DOI":"10.1002\/dmrr.3268","volume":"36","author":"JJ van Netten","year":"2020","unstructured":"van Netten JJ, Bus SA, Apelqvist J, Lipsky BA, Hinchliffe RJ, Game F, et al. Definitions and criteria for diabetic foot Disease. Diabetes Metab Res Rev. 2020;36(Suppl 1):e3268.","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"2056_CR237","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/1753-0407.13372","volume":"15","author":"H Deng","year":"2023","unstructured":"Deng H, Li B, Shen Q, Zhang C, Kuang L, Chen R, et al. Mechanisms of diabetic foot ulceration: a review. J Diabetes. 2023;15(4):299\u2013312.","journal-title":"J Diabetes"},{"key":"2056_CR238","doi-asserted-by":"crossref","unstructured":"Coppelli A, Abbruzzese L, Goretti C, Iacopi E, Riitano N, Piaggesi A. Does Microangiopathy contribute to the pathogenesis of the Diabetic Foot Syndrome? The Diabetic Foot Syndrome. Volume 26. S.Karger AG; 2017. p. 0.","DOI":"10.1159\/000480043"},{"issue":"Suppl 2","key":"2056_CR239","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1078-5884(11)60012-9","volume":"42","author":"M Lep\u00e4ntalo","year":"2011","unstructured":"Lep\u00e4ntalo M, Apelqvist J, Setacci C, Ricco JB, de Donato G, Becker F, et al. Chapter V: Diabetic foot. Eur J Vasc Endovasc Surg. 2011;42(Suppl 2):60\u201374.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2056_CR240","doi-asserted-by":"crossref","unstructured":"Balasubramanian GV, Chockalingam N, Naemi R. The role of cutaneous microcirculatory responses in tissue Injury, inflammation and repair at the foot in Diabetes. Front Bioeng Biotechnol. 2021;9.","DOI":"10.3389\/fbioe.2021.732753"},{"issue":"7","key":"2056_CR241","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s00125-016-3961-0","volume":"59","author":"F Fiordaliso","year":"2016","unstructured":"Fiordaliso F, Clerici G, Maggioni S, Caminiti M, Bisighini C, Novelli D, et al. Prospective study on microangiopathy in type 2 diabetic foot Ulcer. Diabetologia. 2016;59(7):1542\u20138.","journal-title":"Diabetologia"},{"issue":"8","key":"2056_CR242","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.12998\/wjcc.v11.i8.1684","volume":"11","author":"JM Raja","year":"2023","unstructured":"Raja JM, Maturana MA, Kayali S, Khouzam A, Efeovbokhan N. Diabetic foot Ulcer: a comprehensive review of pathophysiology and management modalities. World J Clin Cases. 2023;11(8):1684\u201393.","journal-title":"World J Clin Cases"},{"issue":"12","key":"2056_CR243","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/BF00703132","volume":"28","author":"RG Tilton","year":"1985","unstructured":"Tilton RG, Faller AM, Burkhardt JK, Hoffmann PL, Kilo C, Williamson JR. Pericyte degeneration and acellular capillaries are increased in the feet of human diabetic patients. Diabetologia. 1985;28(12):895\u2013900.","journal-title":"Diabetologia"},{"issue":"2","key":"2056_CR244","first-page":"100","volume":"49","author":"MI Yusof","year":"2008","unstructured":"Yusof MI, Al-Astani AD, Jaafar H, Rashid FA. Morphometric analysis of skin microvasculature in the diabetic foot. Singap Med J. 2008;49(2):100\u20134.","journal-title":"Singap Med J"},{"issue":"5","key":"2056_CR245","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/cs0890467","volume":"89","author":"G Rayman","year":"1995","unstructured":"Rayman G, Malik RA, Sharma AK, Day JL. Microvascular response to tissue injury and capillary ultrastructure in the foot skin of type I diabetic patients. Clin Sci. 1995;89(5):467\u201374.","journal-title":"Clin Sci"},{"issue":"25","key":"2056_CR246","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJM198312223092504","volume":"309","author":"P Raskin","year":"1983","unstructured":"Raskin P, Pietri AO, Unger R, Shannon WA. Jr. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with type I Diabetes Mellitus. N Engl J Med. 1983;309(25):1546\u201350.","journal-title":"N Engl J Med"},{"issue":"3","key":"2056_CR247","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0168-8227(88)80014-7","volume":"4","author":"J Rosenstock","year":"1988","unstructured":"Rosenstock J, Challis P, Strowig S, Raskin P. Improved Diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent Diabetes Mellitus. Diabetes Res Clin Pract. 1988;4(3):167\u201375.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2056_CR248","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10439-022-03134-5","volume":"51","author":"A Coccarelli","year":"2023","unstructured":"Coccarelli A, Nelson MD. Modeling reactive hyperemia to Better Understand and assess microvascular function: a review of techniques. Ann Biomed Eng. 2023;51(3):479\u201392.","journal-title":"Ann Biomed Eng"},{"issue":"7","key":"2056_CR249","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/dmrr.1004","volume":"25","author":"CY Chao","year":"2009","unstructured":"Chao CY, Cheing GL. Microvascular dysfunction in diabetic foot Disease and ulceration. Diabetes Metab Res Rev. 2009;25(7):604\u201314.","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"2056_CR250","doi-asserted-by":"publisher","first-page":"e3244","DOI":"10.1002\/dmrr.3244","volume":"36","author":"S Sharma","year":"2020","unstructured":"Sharma S, Schaper N, Rayman G, Microangiopathy. Is it relevant to wound healing in diabetic foot Disease? Diabetes Metab Res Rev. 2020;36(Suppl 1):e3244.","journal-title":"Diabetes Metab Res Rev"},{"issue":"18","key":"2056_CR251","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.2174\/1381612054367328","volume":"11","author":"T Dinh","year":"2005","unstructured":"Dinh T, Veves A. Microcirculation of the diabetic foot. Curr Pharm Des. 2005;11(18):2301\u20139.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"2056_CR252","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1534734606292281","volume":"5","author":"JC Schramm","year":"2006","unstructured":"Schramm JC, Dinh T, Veves A. Microvascular changes in the diabetic foot. Int J Low Extrem Wounds. 2006;5(3):149\u201359.","journal-title":"Int J Low Extrem Wounds"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02056-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02056-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02056-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:03:36Z","timestamp":1700078616000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02056-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":252,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2056"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02056-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"24 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave consent for the publication of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D. Mauricio is a co-author of this study and an Editorial Board member of the Cardiovascular Diabetology journal. He was not involved in handling this manuscript during the submission and review processes. None of the authors have any conflicts of interest (financial, personal, or otherwise) that might bias the results of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}